BREAKING
Earnings Summary: A snapshot of Duke Energy’s Q4 2025 report 15 hours ago Fiserv (FISV) Earnings: 4Q25 Key Numbers 17 hours ago CVS Health (CVS) Q4 2025 revenue rises 8%; adjusted earnings decline 17 hours ago Chegg Q4 2025 Earnings Soar: New Strategy Stuns Market 1 day ago PAL Q4 2025 Earnings Explode: Mergers Pay Off Now 1 day ago Outdoor Holding Company Q3 2026 Earnings Soar 7% 1 day ago Apollo Q4 2025 Earnings Rocket: Historic AUM Breakthrough 1 day ago Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 2 days ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 2 days ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 2 days ago Earnings Summary: A snapshot of Duke Energy’s Q4 2025 report 15 hours ago Fiserv (FISV) Earnings: 4Q25 Key Numbers 17 hours ago CVS Health (CVS) Q4 2025 revenue rises 8%; adjusted earnings decline 17 hours ago Chegg Q4 2025 Earnings Soar: New Strategy Stuns Market 1 day ago PAL Q4 2025 Earnings Explode: Mergers Pay Off Now 1 day ago Outdoor Holding Company Q3 2026 Earnings Soar 7% 1 day ago Apollo Q4 2025 Earnings Rocket: Historic AUM Breakthrough 1 day ago Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 2 days ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 2 days ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 2 days ago
ADVERTISEMENT
AlphaGraphs

Hormel Foods (HRL) Q4 2024 sales and earnings meet estimates

Hormel Foods Corporation (NYSE: HRL) Wednesday reported a decline in sales for the fourth quarter of 2024. The results came in line with analysts’ estimates. Adjusted earnings remained unchanged at $0.42 per share in the fourth quarter, in line with Wall Street’s forecast. Net income attributable to the company was $220.2 million or $0.40 per […]

$HRL December 4, 2024 1 min read

Hormel Foods Corporation (NYSE: HRL) Wednesday reported a decline in sales for the fourth quarter of 2024. The results came in line with analysts’ estimates.

Hormel Foods Q4 2024 earnings infographic

Adjusted earnings remained unchanged at $0.42 per share in the fourth quarter, in line with Wall Street’s forecast. Net income attributable to the company was $220.2 million or $0.40 per share, compared to $195.9 million or $0.36 per share in the year-ago quarter.

Net sales decreased modestly to $3.14 billion in the October quarter from $3.20 billion in the comparable period in fiscal 2023. The latest number matched analysts’ estimates. For fiscal 2025, the management expects net sales to be in the range of $11.9 billion to $12.2 billion and sees full-year organic sales growth of 1- 3%.

Prior Performance

ADVERTISEMENT
ADVERTISEMENT